IDEAYA Biosciences IDYA

$ 30.0 0.0%

Quarterly report 2024-Q3
added 11-04-2024

IDEAYA Biosciences Income Statement 2011-2024 | IDYA

Annual Income Statement IDEAYA Biosciences

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	2.51 B	746 M	584 M	435 M	107 M	-	-	-	-	-	-	-	-
Shares	57.5 M	41.4 M	35.3 M	24.7 M	12.5 M	-	-	-	-	-	-	-	-
Historical Prices	43.7	18	16.6	17.6	8.55	-	-	-	-	-	-	-	-
Net Income	-113 M	-58.7 M	-49.8 M	-34.5 M	-42 M	-34.3 M	-11.9 M	-	-	-	-	-	-
Revenue	23.4 M	50.9 M	27.9 M	19.5 M	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-134 M	-62.5 M	-50.3 M	-35.3 M	-44.3 M	-36.4 M	-14.4 M	-	-	-	-	-	-
Interest Expense	-	-	-	-	8 K	77 K	2.43 M	-	-	-	-	-	-
EBITDA	-132 M	-60.4 M	-48.5 M	-34 M	-43 M	-35.5 M	-14 M	-	-	-	-	-	-
Operating Expenses	158 M	113 M	78.2 M	54.9 M	44.3 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	28.3 M	23.9 M	20.1 M	15.2 M	9.95 M	4.67 M	2.05 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement IDEAYA Biosciences

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	86.2 M	78 M	75.1 M	65 M	60 M	56.3 M	48.4 M	48.2 M	40.3 M	38.7 M	38.6 M	38.5 M	37.8 M	32.9 M	31.8 M	29.5 M	28.4 M	21 M	20.3 M	20.3 M	20.2 M	8.22 M	1.1 M	1.34 M	999 K	936 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-51.8 M	-52.8 M	-39.6 M	-	-27.4 M	-27.9 M	-23.6 M	-	1.62 M	-22.1 M	-14 M	-	-11.6 M	-10.9 M	-9.02 M	-	-4.93 M	-12.4 M	-12 M	-10.8 M	-11 M	-10.7 M	-9.57 M	-8.56 M	-13.1 M	-7 M	-5.74 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	8.04 M	3.54 M	7.88 M	-	29.7 M	5.85 M	11.4 M	-	8.98 M	8.76 M	7.25 M	-	8.97 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-66.9 M	-64.9 M	-51 M	-	-33.5 M	-32.7 M	-26.3 M	-	660 K	-22.5 M	-14.2 M	-	-11.7 M	-11.1 M	-9.14 M	-	-5 M	-12.6 M	-12.5 M	-	-11.6 M	-11.2 M	-10.1 M	-	-13.6 M	-7.57 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6 K	-	-	1 K	8 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-66.3 M	-64.3 M	-50.4 M	-	-32.9 M	-32.1 M	-25.7 M	-	1.26 M	-22 M	-13.8 M	-	-10.4 M	-10.2 M	-8.75 M	-	-3.98 M	-11.9 M	-12.1 M	-	-10.7 M	-10.6 M	-9.8 M	-	-13 M	-7.17 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	66.9 M	64.9 M	51 M	-	41.6 M	36.3 M	34.2 M	-	29 M	28.4 M	25.6 M	-	20.7 M	19.8 M	16.4 M	-	14 M	12.6 M	12.5 M	11.3 M	11.6 M	11.2 M	10.1 M	9.13 M	13.6 M	7.57 M	6.09 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	9.74 M	10.4 M	8.21 M	-	7.86 M	7.08 M	6.3 M	-	6.67 M	5.55 M	5.92 M	-	5.19 M	4.83 M	4.82 M	-	3.94 M	3.99 M	3.45 M	-	2.7 M	2.38 M	2.1 M	-	1.09 M	1.14 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency